Speaking Engagements (Staff, Collaborators, Strategic Partners)

Speaking Engagements (Staff, Collaborators, Strategic Partners)


March 31 - 31, 2022

Mark Trusheim for FoCUS

March 30 - 30, 2022
Chicago, IL

Mark Trusheim, Michael Ciarametaro, and Kim Caldwell for FoCUS

February 23 - 23, 2022

Mark Trusheim for FoCUS

February 8 - 8, 2022

Mark Trusheim for FoCUS


November 30 - 30, 2021

Jane Barlow and Brendan Hayes participated in the Great Lakes Hemophilia Foundation's Comprehensive Gene Therapy Symposium on November 30. 

November 25 - 25, 2021

Casey Quinn participated in the HTX Expert Forum on November 25.

October 28 - 28, 2021

Mark Trusheim participated in the the APEC Finance Ministers' Meeting on October 28.

October 22 - 22, 2021

Mark Trusheim participated in the the McKinsey CGT Roundtable on October 22 

October 19 - 19, 2021
Denver, CO

Jane Barlow will join the AMCP Nexus 2021 in Denver, in a session "Addressing Gene Therapy Financial Challenges: A survey of emerging market solutions" with Michelle Harika on October 19.

October 11 - 11, 2021

Jane Barlow will join the Alliance for Innovation in Integrated Healthcare (AIIH) Summit in NYC: Impact of Cell and Gene Therapy panel on October 11. 

October 7 - 7, 2021

Mark Trusheim participated in the Advanced Regenerative Manufacturing Institute fall meeting on October 7, presenting FoCUS's reimbursement research. 

September 22 - 22, 2021

Jane Barlow discussed FoCUS emerging market solutions research at the Huron Virtual Roundtable discussion "Unlocking the Full Potential of Outcomes Based Contracting Work for CGT: Collaborate or Compete?" on September 22.

September 22 - 28, 2021

Mark Trusheim participated in the ASCGT Policy Forum panel "The Status of Medicaid Coverage and Access for Gene and Cell Therapies" on September 22, and on September 28 he led the roundtable "Preparing for 2022 regulatory change and the performance-based contracting explosion" for the Reuters Cell and Gene Therapy USA meeting. On September 30 Mark spoke in the OHE Master Class Adaptive Pathways: Generating Evidence of Value.

August 25 - 27, 2021

Mark Trusheim participated in the World Orphan Drug Congress USA 2021 on August 25–27.

July 20 - 21, 2021

Mark Trusheim participated in the BCBSA 2021 Specialty Pharmacy Conference on July 20–21.

June 17 - 17, 2021

Precision therapies are often approved based on small trials, in specialized settings, and using biomarkers as endpoints.  Thus, despite their potential high cost, the evidence of value is lacking which makes real-world evidence crucial. Join Schaeffer Center Director of Research Darius Lakdawalla in discussion with MIT NEWDIGS Director of Research Kay Larholt and Merck Center for Observational and Real-World Evidence Executive Director Megan O’Brien for a discussion about how we should measure and leverage real-world data to assess the value of precision medicines.

... Learn more

April 12 - 12, 2021

On April 12 Mark Trusheim led a workshop for ISPOR, entitled “Adaptive Reimbursement: Innovating for Patient Access and Better Outcomes for All”, including Angela Banks Vice President, External Affairs, UnitedHealth Group; Ron Potts, MD; Medical Director Quality Improvement Kaiser Permanente, Chief Medical Officer, INTERLINK; and David Strutton, PhD, VP, Global Pharmaceuticals & Policy Research, Center for Observational and... Learn more

February 26 - 26, 2021

NEWDIGS Executive Director Gigi Hirsch moderated the midday keynote fireside chat at the MIT Sloan 2021 Healthcare and Bioinnovations Conference, on the topic "The Value of Downstream Innovation - Improving Patient Access to Groundbreaking Therapies". 

February 22 - 22, 2021

Mark Trusheim spoke at on the panel "Collecting & Utilizing Data to Support Gene Therapy Market Access" at the 4th Annual Gene Therapy for Rare Disorders conference representing FoCUS.

February 17 - 17, 2021

Mark Trusheim participated as a panelist in the BioNJ Cell & Gene Therapy Market Access Program for FoCUS

February 9 - 9, 2021

Mark Trusheim presented "Models of Paying for High-Cost Cellular Therapies" at the 2021 Meetings of the ASTCT and CIBMTR 

January 26 - 26, 2021

Mark Trusheim spoke at a California Life Sciences Association briefing on January 26. The briefing was well attended, and the audience included California state legislators.


June 23 - 23, 2020
Online: https://www.fiercevirtual.com

Kay Larholt will represent NEWDIGS in a panel:

Real-world evidence: Another "gold standard" for drugmakers?

June 23 at 1 p.m. ET

In their hunt for new approvals, biopharma companies spend billions of dollars every year on clinical trials. In recent years, though, real-world studies as sources of practice-informing data––and even as the basis for new indications––have multiplied. but clinical trials remain the gold standard.

In a post-pandemic future, will clinical trials ever look the same again? Could real-world data help fill in the gaps? In this session, we will discuss the role real-world... Learn more

June 20 - 20, 2020

Gigi Hirsch will present LEAPS and the RA MA Pilot 

May 1 - 1, 2020
Oxon Hill, MD

Mark Trusheim for FoCUS

April 21 - 21, 2020
Madison, WI

Jane Barlow for FoCUS

April 15 - 16, 2020
Philadelphia, PA

Mark Trusheim for FoCUS

April 7 - 9, 2020
Los Angeles, CA

Mark Trusheim for NEWDIGS

March 30 - 2, 2020
Boston, MA

Mark Trusheim for FoCUS

March 23 - 25, 2020
Carlsbad, CA

Jane Barlow for FoCUS

February 28 - 28, 2020
MIT, Cambridge, MA


Lunch Fireside Chat:

  • Noubar Afeyan, PhD, Founder & CEO, Flagship Pioneering
  • Gigi Hirsch, MD, Executive Director, Center for Biomedical Innovation, Massachusetts Institute of Technology
February 21 - 21, 2020
Orlando, FL

Mark Trusheim for FoCUS

February 13 - 13, 2020
Washington, DC

Mark Trusheim for FoCUS

February 7 - 7, 2020
Orlando, FL

Danielle Rollmann will represent FoCUS in a panel titled: Guiding the Future of Pharmacy Benefits: Adapting to Gene Therapy and Ultra High-Cost Drugs to Make Leading-edge Care Affordable

February 6 - 7, 2020
Washington, DC

Mark Trusheim will represent FoCUS

January 31 - 31, 2020
Tufts Clinical and Translational Science Institute, Boston, MA

Gigi Hirsch will present the research taking place through NEWDIGS 

January 29 - 29, 2020
Boston, MA

Mark Trusheim for FoCUS


November 15 - 15, 2019
Cambridge, MA

Gigi Hirsch will present LEAPS

October 29 - 30, 2019
Bethesda, MD

Mark Trusheim will represent NEWDIGS

October 29 - 29, 2019
Washington, DC

Gigi Hirsch will present LEAPS in a panel entitled Flipping the Script: Designing the System to Deliver for Patients.

  • Livestreamed panels can be viewed here.  The panel is scheduled for 3:45-4:45pm
October 29 - 29, 2019
Boston, MA

Kay Larholt will represent NEWDIGS and LEAPS in a panel discussion titled: Getting Real: The Changing Tide on Real-World Evidence in Drug Development

October 23 - 23, 2019
Washington, DC

Gigi Hirsch and Kay Larholt have been invited to present Learning Ecosystems Accelerator for Patient-Centered, Sustainable Innovation (LEAPS) Project in a closed forum meeting.

The 30-minute presentation will be followed by a 45-minute informal discussion with the Forum membership moderated by the Forum co-chairs (Rob Califf and Greg Simon).

October 2 - 4, 2019
Carlsbad, CA

Jane Barlow represents FoCUS 

September 26 - 26, 2019
New York City, NY

Mark Trusheim will represent FoCUS in a panel titled: Pricing Pressures for 2020 and Beyond

September 17 - 17, 2019
Cambridge, MA

Colin Young for the FoCUS Project

September 11 - 11, 2019
Washington, DC

Mark Trusheim will speak for FoCUS at this Duke-Margolis Center for Health Policy public workshop.

June 23 - 26, 2019
Orlando, FL

Jane Barlow for the FoCUS Project

June 14 - 14, 2019
Boston, MA

"Delve into the Evolving Reimbursement Landscape and Developments in Payer Policy"
Mark Trushiem for FoCUS

May 10 - 10, 2019
Rockville, MD

Mark Trusheim has been invited to speak.


May 4 - 4, 2019
New Orleans, LA

Mark Trusheim for FoCUS

April 4 - 4, 2019
Montreal, Ontario, Canada

Casey Quinn will represent the FoCUS Project in a Panel titled: HTA Reimbursement and Payment of Gene Therapy for Hemophilia

April 2 - 2, 2019
Cambridge, MA

12:00 PM Panel: Towards an “Agile” Regulatory Framework (45 mins)

Chaired by Gigi Hirsch, Massachusetts Institute of Technology

Paul Howard, Food and Drug Administration
Anne-Virginie Eggimann, bluebird bio
Ed Pezalla, Enlightenment Bioconsult
John Ferguson, Sanofi

March 27 - 27, 2019
Boston, MA

Mark Trusheim will present:
Precision Fiancing Framework and Pilots: MIT FoCUS Consortium Findings

March 25 - 28, 2019
San Diego, CA

Jane Barlow will represent the FoCUS Project

February 26 - 26, 2019
Cambridge, MA

Gigi Hirsch presented LEAPS:

From Bigger Data to Smarter Evidence

As health data increasingly scale and go digital, the prevailing attitude has been a big data approach, where whoever has the most data wins. However, the creation of vast amounts of data has not translated to useful evidence in many cases, particularly as biopharmaceutical innovation and healthcare systems evolve toward precision medicine, patient-centered innovation, and value-based reimbursement models where reliable, targeted, and fit-for-purpose evidence is key to matching the appropriate treatments to patients.  NEWDIGS is leading a... Learn more


December 12 - 12, 2018
Cambridge, MA

Casey Quinn will present FoCUS learnings at the MIT Center for Biomedical Innovation's BioMANufacturing Program Summit

November 7 - 7, 2018
Boston, MA

Mark Trusheim, for NEWDIGS, facilitating working sessions for this Harvard-MIT Center for Regulatory Science and BIO joint workshop.

October 30 - 31, 2018
New York, NY

Kimberly Freeman, for FoCUS

October 29 - 29, 2018
Silver Spring, MD

Mark Trusheim, for NEWDIGS

The FDA Oncology Center of Excellence, in collaboration with theUCSF-Stanford Centers of Excellence in Regulatory Science and Innovation (CERSI) will hold a public workshop to explore clinical trial designs and innovations that will aid in ioptimizing outcomes in early breast cancer.

October 22 - 24, 2018
Washington, DC

Mark Trusheim, for NEWDIGS

More information here.

October 22 - 25, 2018
Orlando, FL

Jane Barlow for FoCUS
AMCP Nexus 2018

October 3 - 5, 2018
La Jolla, CA

Colin Young, FoCUS, presenting a poster on Pipeline Research

September 24 - 24, 2018
Washington, DC

Mark Trusheim
ASGCT Value Summit

September 11 - 11, 2018
Dallas, TX

R. John Glasspool for FoCUS
MCRA 2018 Conference

May 19 - 23, 2018
Baltimore, MD

Jane Barlow for FoCUS

May 10 - 10, 2018
New York, NY

Mark Trusheim

May 8 - 9, 2018
Stanford, CA

R. John Glasspool & Gigi Hirsch
Leaders in Global Healthcare & Technology

May 5 - 5, 2018
Chicago, IL

Mark Trusheim for FoCUS


May 2 - 2, 2018
Beverly Hills, CA

Mark Trusheim for FoCUS
"Paying for the High Cost of Cures"

March 26 - 26, 2018
Paris, France

R. John Glasspool & Casey Quinn for FoCUS

March 21 - 22, 2018
Budapest, Hungary

Ariel Stern and Mark Trusheim will facilitate a day of interactive discussions on MAPPS and the Adapt Smart consortium using NEWDIGS Scenario Design Lab methodology


November 14 - 14, 2017
Washington, DC

(R. John Glasspool) Duke-Margolis Center for Health Policy Workshop

October 24 - 25, 2017
Washington, DC

(Kay Larholt) Real World Evidence Discussions & Overview of Related Projects

July 12 - 12, 2017
Boston, MA
May 24 - 24, 2017
Boston, MA

(Mark Trusheim) Adaptive Pathways and Platform Trials Discussion

May 10 - 11, 2017
Palo Alto, CA

(Gigi Hirsch) Panel: Real World Evidence: Hype or Reality? (John Glasspool, Moderator)

April 27 - 27, 2017
Boston, MA

(Mark Trusheim) Panel: Gene Therapy: Commercialization Readiness & Market Access Challenges

January 23 - 23, 2017
Washington, DC

(Gigi Hirsch) Panel: Adaptive Biomedical Innovations: The Way Forward (Stella Blackburn, Moderator)


December 12 - 12, 2016
Washington, DC

hosted by the National Cancer Policy Forum. (G.K. Raju)

October 5 - 5, 2016
La Jolla, CA

“The Impact of a New Healthcare Model: What Do Payers Think of Gene Therapies?” (Mark Trusheim)

September 21 - 21, 2016
New York, NY

NBER Pre-Conference on Economic Dimensions of Personalized and Precision Medicine

June 29 - 29, 2016
Philadelphia, PA

“Europe and the US: Making Outcomes-Based Health Care Possible.” Details here. (Gigi Hirsch).

June 26 - 30, 2016
Philadelphia, PA

(Gigi Hirsch & Hans-Georg Eichler – Session Co-Chairs).

June 8 - 8, 2016
San Francisco, CA

“Curative Therapies: Aligning Policy with Science to Ensure Patient Access” (Mark Trusheim).

April 21 - 22, 2016
Duke University, Durham, NC

“Adaptive Pathways and Biomedical Innovation in the EU, US and Japan” (Ken Oye).

April 21 - 22, 2016
Washington, DC

“Adaptive Biomedical Innovation: Re-engineering How We Innovate” (Gigi Hirsch).

April 14 - 14, 2016
Basel, Switzerland
March 21 - 22, 2016
San Francisco, CA

co-sponsored by Silicon Valley Executive Network (SVEN), Decision Resources Group, and MIT Media Lab. “Adaptive Biomedical Innovation: Transforming Big Data Hype into Patient Value” (Tom Unger).

March 17 - 18, 2016

Belgian Healthcare Knowledge Center (HKC) & WHO jointly sponsored Drug Pricing Scenarios Project (Report to be presented to Dutch EU Presidency in June 2016) – Part 1 (Mark Trusheim).

January 27 - 29, 2016
Washington, DC

Panel Debate on “Earlier Access vs. Safety?” (Hans-Georg Eichler & Ken Oye).